Renal effects of a sodium‐glucose cotransporter 2 inhibitor, tofogliflozin, in relation to sodium intake and glycaemic status

AIMS: Little is known about whether sodium intake is associated with the clinical effects of SGLT2 inhibitors (SGLT2is); however, SGLT2is may increase urinary sodium excretion. Thus, we investigated the impact of daily sodium intake on the estimated glomerular filtration rate (eGFR) via an SGLT2i, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nunoi, Kiyohide, Sato, Yuichi, Kaku, Kohei, Yoshida, Akihiro, Suganami, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619387/
https://www.ncbi.nlm.nih.gov/pubmed/30945431
http://dx.doi.org/10.1111/dom.13731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619387/
https://www.ncbi.nlm.nih.gov/pubmed/30945431
http://dx.doi.org/10.1111/dom.13731

Ejemplares similares